Previous close | 267.90 |
Open | 267.90 |
Bid | 267.20 x N/A |
Ask | 269.70 x N/A |
Day's range | 267.90 - 267.90 |
52-week range | 250.60 - 387.20 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The first-quarter results for Bio-Rad Laboratories, Inc. ( NYSE:BIO ) were released last week, making it a good time to...
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.